Proteasome inhibitors for treating cancer

Details for Australian Patent Application No. 2010300259 (hide)

Owner Janssen Pharmaceutica NV

Inventors De Coster, Roland; Van De Velde, Helgi; Bayssas, Martine

Agent Shelston IP

Pub. Number AU-A-2010300259

PCT Pub. Number WO2011/038924

Priority 61/247,714 01.10.09 US

Filing date 1 October 2010

Wipo publication date 7 April 2011

International Classifications

A61K 31/00 (2006.01)

A61K 31/69 (2006.01) - Boron compounds

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

26 April 2012 PCT application entered the National Phase

  PCT publication WO2011/038924 Priority application(s): WO2011/038924

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010300271-Production of calcium carbonate

2010300248-Method and device for comminuting ore